1. Iterative sure independent ranking and screening for drug response prediction
   Biao An et al, 2020, BMC Medical Informatics and Decision Making CrossRef
2. Therapeutic Potential of Heat Shock Protein 90 Inhibitors, Geldanamycin, and Analog Compounds in Precision Cancer Therapy
   Atta Mohammed Alzebari et al, 2023, BioMed Target Journal CrossRef
3. Dual down‐regulation of EGFR and ErbB2 by berberine contributes to suppression of migration and invasion of human ovarian cancer cells
   Tzu‐Chao Chuang et al, 2021, Environmental Toxicology CrossRef
4. Debio-0932, a second generation oral Hsp90 inhibitor, induces apoptosis in MCF-7 and MDA-MB-231 cell lines
   Aykut Özgür et al, 2021, Molecular Biology Reports CrossRef
5. Inhibition of Heat Shock Protein 90 as a Novel Platform for the Treatment of Cancer
   Chang Gao et al, 2019, Current Pharmaceutical Design CrossRef
6. Development of machine learning models for the screening of potential HSP90 inhibitors
   Mohd Imran Khan et al, 2022, Frontiers in Molecular Biosciences CrossRef
7. Carboxy-terminus Hsc70 interacting protein exerts a tumor inhibition function in head and neck cancer
   Meng Xiao et al, 2017, Oncology Reports CrossRef
8. Enhancing therapeutic efficacy in breast cancer: a study on the combined cytotoxic effects of doxorubicin and MPC-3100
   Nazan Gökşen Tosun, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
9. Exploration and optimisation of structure-activity relationships of new triazole-based C-terminal Hsp90 inhibitors towards in vivo anticancer potency
   Jaka Dernovšek et al, 2024, Biomedicine & Pharmacotherapy CrossRef
10. Heat shock protein 90 (HSP90) inhibitors in gastrointestinal cancer: where do we currently stand?—A systematic review
    Christian Tibor Josef Magyar et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
11. Connecting signaling and metabolic pathways in EGF receptor-mediated oncogenesis of glioblastoma
    Arup K. Bag et al, 2019, PLOS Computational Biology CrossRef